LataMed AI Collaborates with Universidad Central de Venezuela Faculty of Medicine to Advance HealthTech Education

LataMed AI Corp. partners with UCV's Faculty of Medicine for educational sessions on digital health and AI, aiming to foster innovation among future healthcare professionals in Latin America.

LA Metrowire Staff
Education
LataMed AI Collaborates with Universidad Central de Venezuela Faculty of Medicine to Advance HealthTech Education

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Venezuelan operating affiliate, LataMed AI VE, has accepted an invitation from the Faculty of Medicine at Universidad Central de Venezuela (UCV) to participate in educational sessions focused on HealthTech innovation, digital healthcare technologies, and artificial intelligence applications in healthcare environments.

According to the Company, the sessions are expected to provide students and faculty members with exposure to emerging healthcare technologies, telehealth infrastructure concepts, healthcare coordination tools, healthcare analytics, emergency response technologies, and evolving applications of artificial intelligence within healthcare delivery systems.

Management believes this academic engagement represents a strategic opportunity to increase awareness of digital healthcare innovation among future healthcare professionals and to foster dialogue regarding technology-enabled healthcare solutions throughout Latin America. The Company further believes that collaboration between healthcare technology developers and academic institutions may contribute to broader understanding of telehealth, healthcare accessibility, provider coordination, and data-driven healthcare operations.

Participation in the UCV program is expected to provide an opportunity for the Company to engage with future physicians, healthcare leaders, researchers, and educators regarding developments in digital health infrastructure and emerging healthcare technologies. The educational sessions are intended solely for academic and informational purposes and do not constitute endorsements, commercial arrangements, recommendations, or evaluations of any specific products, services, or technologies.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We are honored to engage with students and faculty members at one of Venezuela’s most respected academic institutions. We believe meaningful collaboration between healthcare professionals, educators, and technology innovators is increasingly important as healthcare systems evaluate digital solutions designed to improve access, coordination, efficiency, and patient outcomes. Educational initiatives such as this support knowledge sharing and encourage discussion regarding the future role of digital healthcare technologies across Latin America.”

For additional information, please visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

LataMed AI Corp. (OTC: LMED) is a development-stage digital health and artificial intelligence technology company focused on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. The Company’s strategy is centered on developing technology platforms designed to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, and data-driven healthcare operations, with an initial regional focus on Latin America.